个人简介
教育背景
2004.8 —2009.7：沈阳药科大学，药学院药学（英语）专业，理学学士
2009.8 —2014.5：美国南伊利诺伊大学医学院医学微生物学、免疫学及细胞生物学系及西蒙癌症研究中心，理学博士
2014.7 —2015.5：美国斯坦福大学医学院，博士后
工作经历
2015.7 —今：天津医科大学生药教研室，讲师
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Yu Y., Walia V & Elble, R. C. (2013). Loss of CLCA4 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer Cells. PLoS One. 2013 Dec 26;8(12):e83943.
2. Yu Y, Elble RC.Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer Progression.J Clin Med. 2016 Feb 18;5(2).Review.
3. Yu, Y., Ramena, G., & Elble, R. C. (2012). The role of cancer stem cells in relapse of solid tumors. Front Biosci (Elite Ed), 4, 1528-1541. Review.
4. Li XY, Yu Y, Jia M, Jin MN, Qin N, Zhao C, Duan HQ.Terminamines K-S, Antimetastatic Pregnane Alkaloids from the Whole Herb of Pachysandra terminalis.Molecules. 2016 Sep 26;21(10). pii: E1283.
5. Ramena G, Yin Y, Yu Y, Walia V, Elble RC.CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.PLoS One. 2016 Mar 1;11(3)
6. Gan CC, Ni TW, Yu Y, Qin N, Chen Y, Jin MN, Duan HQ.Flavonoid derivative (Fla-CN) inhibited adipocyte differentiation via activating AMPK and up-regulating microRNA-27 in 3T3-L1 cells.Eur J Pharmacol. 2017 Feb 15;797:45-52.
7. Walia, V., Yu, Y., Cao, D., Sun, M., McLean, J. R., Hollier, B. G., . . . Elble, R. C. (2012). Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis. Oncogene, 31(17), 2237-2246. doi: 10.1038/onc.2011.392
京公网安备 11010802027423号